| Literature DB >> 25960674 |
Claudia Horn-Hofmann1, Patricia Büscher2, Stefan Lautenbacher3, Jörg Wolstein2.
Abstract
PURPOSE: Alcohol is believed to have pain-dampening effects and is often used as self-medication by persons with pain problems; however, experimental evidence confirming this effect is scarce. We conducted a systematic review of experimental studies on the effects of nonrecurring alcohol administration on pain perception in healthy human subjects and the underlying mechanisms.Entities:
Keywords: alcohol; experimental pain; pain
Year: 2015 PMID: 25960674 PMCID: PMC4412487 DOI: 10.2147/JPR.S79618
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Search query
| (alcohol OR ethanol) and (analgesia OR analgesic effect OR analgetic effect OR pain perception) NOT animals NOT block NOT cancer NOT chronic NOT injection NOT management NOT mice NOT rats NOT surgery NOT review NOT topical NOT withdrawal |
Experimental measures of pain perception
| Measure of pain perception | Description |
|---|---|
| Pain threshold | Stimulus intensity that is experienced as beginning pain |
| Pain tolerance | Maximum stimulus intensity that can be tolerated |
| Pain intensity | Subjective evaluation of the degree of pain sensation evoked by a certain stimulus on a rating scale (NRS or VAS) |
| Pain unpleasantness | Subjective evaluation of the degree of pain-related negative effect evoked by a certain stimulus on a rating scale (NRS or VAS) |
Abbreviations: NRS, numerical rating scale; VAS, visual analog scale.
General design of studies
| Reference | Subjects
| Experimental manipulations
| ||||||
|---|---|---|---|---|---|---|---|---|
| N | Age, years (mean [M]/range) | Sex | Design | Placebo control | Blinding | Randomization | Baseline control | |
| 19 | 60 | M=23.60 | Mixed | Within subject | Yes | Double blind | Yes | Yes |
| 20 | 48 | M=23.71 | Mixed | Within subject | Yes | Double blind | Yes | Yes |
| 22 | 8 | 19–28 | Mixed | Within subject | Yes | Double blind | Yes | Yes |
| 21 | 11 | M=24 | Mixed | Within subject | Yes | Double blind | Not specified | No |
| 27 | 81 | 18–30 | Male | Between subject | Yes | Double blind | Not specified | Yes |
| 23 | 18 | 21–30 | Female | Within subject | Yes | Double blind | Yes | Yes |
| 26 | 8 | M=31.90 | Male | Within subject | No | Not specified | Yes | No |
| 30 | 20 | M=37.45 | Male | Within subject | Yes | None | Yes | Yes |
| 29 | 52 | M=35.0 | Male | Between subject | Yes | None | Yes | Yes |
| 32 | 8 | Not reported | Male | Within subject | Yes | Double blind | Yes | Yes |
| 25 | 50 | M=38.6 | Male | No control condition | No | None | No | Yes |
| 28, experiment 1 | 7 | Not reported | Male | Within subject | Yes | Single blind | Yes | Yes |
| 28, experiment 2 | 7 | Not reported | Male | Within subject | No | Single blind | Yes | Yes |
| 1 | 51 | Not reported | Male | Between subject | Yes | Double blind | Yes | Yes |
| 24 | 79 | M=44.3 | Male | No control condition | No | None | No | Yes |
Notes:
As these two publications derive from the same experimental investigation, they are counted as one experiment;
as this investigation contains the results of two experiments, both experiments are listed separately.
Characteristics of alcohol administration
| Reference | Mode of administration | Time interval for consumption of drink | Administered dose of alcohol (g/kg) | Interval between alcohol administration and pain testing | Assessment of BAC/BrAC | Mean BAC/BrAC (mg/dL) |
|---|---|---|---|---|---|---|
| 19 | IV | Not applicable | Low dose: 0.38; high dose: 0.94 | 30 minutes after targeted BAC had been reached | Continuous monitoring (clamp procedure) | Low dose: 43.7; high dose: 100 |
| 22 | Oral | 10 minutes | 0.7 for females; 0.8 for males | 120 minutes after start of the drink | Assessment of BAC 0, 20, 65, 75, and 120 minutes after start of the drink | 84 (65 minutes postdrink) |
| 21 | Oral | 10 minutes | Low dose: 0.25; high dose: 0.5 | 55–60 minutes after start of the drink | Assessment of BrAC 15, 55, 80, 110, and 140 minutes after completion of drink | Low dose: 31/20; high dose: 62/54 (15/55 minutes postdrink) |
| 27 | Oral | 15–20 minutes | Active placebo: 0.10; low dose: 0.38; medium dose: 0.57; high dose: 0.76 | 10–15 minutes after completion of the drink | Assessment of BrAC immediately after pain testing | Active placebo: 1; low dose: 63; medium dose: 85; high dose: 88 |
| 23 | Oral (placebo IV) | Not reported | 0.8 | 90 minutes after completion of the drink | Not assessed/reported | |
| 26 | Oral | 15 minutes | 0.8 | 45 minutes after start of the drink | Assessment of BAC 45 minutes and 60 minutes after start of the drink | Before pain testing: 76; after pain testing: 71 |
| 30 | Oral | 20 minutes | 0.5 | 35 minutes after start of the drink | Assessment of BrAC 37 minutes after start of the drink | 60 |
| 29 | Oral | 10 minutes | 0.244 | 25 minutes after start of the drink | Not assessed | |
| 32 | IV | Loading dose of 0.6 followed by a constant infusion of 0.002 | 35 minutes after start of alcohol infusion | Assessment of BrAC immediately after pain testing | 87 | |
| 25 | Oral | Drink 1: 15 minutes; drink 2: 20 minutes | Drink 1: 0.261; drink 2: 0.521 (total: 0.782) | 15 minutes after ingestion of each drink | Not assessed | Not assessed |
| 28, experiment 1 | IV | Not applicable | 1.2 | 15, 30, 45, and 60 minutes after start of infusion | Assessment of BAC every 15 minutes | Data not reported |
| 28, experiment 2 | IV | Not applicable | 0.6 | 15, 30, 45, and 60 minutes after start of infusion | Assessment of BAC every 15 minutes | Data not reported |
| 1 | Oral | Not reported | Low dose: 0.32; high dose: 0.63 | 40 minutes after start of the drink | Assessment of BrAC immediately before and after pain testing | Data not reported |
| 24 | Oral | Not reported | Drink 1: 0.261; drink 2: 0.521 (total: 0.782) | Not specified | Not assessed | Not assessed |
Notes:
Indication of quantity of the administered dose has been transformed in g/kg of 100% alcohol for a better comparability between studies;
amount of alcohol adjusted to reach a targeted BAC by using a clamp procedure;
as these two publications derive from the same experimental investigation, they are counted as one experiment;
as this investigation contains the results of two experiments, both experiments are listed separately.
Abbreviations: BAC, blood alcohol concentration; BrAC, breath alcohol concentration; IV, intravenous.
Methods of pain induction and pain measurement and main results concerning alcohol effects on pain perception
| Reference | Sample | Design | Pain induction | Measure of pain perception | Main findings regarding alcohol effect on pain measures | Additional findings regarding moderating variables |
|---|---|---|---|---|---|---|
| 20 | Subsample of Perrino et al, | Within subject: high alcohol, low alcohol, placebo Between subject: family history of alcoholism (positive vs negative), Ne (high vs low) | Electrical stimulation (volar surface of the distal forearm) | Pain threshold | Pain threshold: no alcohol effect | Family history of alcoholism and neuroticism: Interaction effect: increased pain tolerance after low dose in subjects with high Ne and FHP |
| 19 | N=60 (32 male; 41 FHN, 19 FHP) | Within subject: high alcohol, low alcohol, placebo Between subject: family history of alcoholism (positive vs negative) | Electrical stimulation (volar surface of the distal forearm) | Pain threshold | Pain threshold: no alcohol effect | Family history of alcoholism: Pain-dampening effect only in FHN subjects |
| 22 | N=8 (4 male) | Within subject: alcohol vs placebo | von Frey hairs | Pain threshold | Pain threshold: no alcohol effect | No moderating variables assessed |
| 21 | N=11 (9 male) | Within subject: high-dose alcohol vs low-dose alcohol vs placebo | Cold pressor test (3 minutes, nondominant arm) | Pain intensity rating (VAS 0–10) | Pain intensity rating: no alcohol effect | No moderating variables assessed |
| 27 | N=81 (all male; 39 FHP; 42 FHN) | Between subject: active placebo vs low-/medium-/high-dose alcohol; family history of alcoholism (positive vs negative) | Electrical stimulation (inside of the right elbow) | Pain intensity rating (NRS 0–10) | Pain intensity rating: pain-dampening effect of the high alcohol dose; increase in perceived pain in the active placebo group | Family history of alcoholism: FHP men reported more pain and discomfort overall during shock |
| 23 | N=14 (all female) | Within subject: saline (IV) vs morphine (IV) vs sulfate (IV) vs alcohol (orally) | Pressure (Achilles tendon) | Pain threshold | Pain threshold: no alcohol effect | No moderating variables assessed |
| 26 | N=8 (all male) | Within subject: sober vs alcohol | Electrical stimulation | Scale calibration (“definitely unpleasant”) | Scale calibration: pain-dampening effect of alcohol | No moderating variables assessed |
| 30 | N=20 (all male) | Within subject: alcohol vs placebo vs control | Cold pressor test (1 minute; hand to the wrist) | Slope index of increasing pain (on the basis of verbal report at intervals of 5 seconds) | Slope index of increasing pain: pain-dampening effect of alcohol Naloxone condition: no main effect of naloxone administration | Drinking experience (DAS) |
| 29 | N=56 (all male) | Between subject: alcohol vs placebo; alcohol vs placebo instruction; drinking experience | Cold pressor test (1 minute; hand to the wrist) | Highest level of verbal report at intervals of 5 seconds | No main effects of alcohol reported | Drinking experience: Interaction of drinking experience and beverage instruction on pain reports. Men with high scores on two scales showed reduced pain when told they had consumed alcohol and increased pain when told they had consumed tonic |
| 32 | N=8 (all male) | Within subject: alcohol vs morphine; before vs after naloxone injection | Pressure (bare area of the tibia) | Pain threshold | Pain threshold: pain-dampening effect of alcohol and morphine; no differences between the treatments | No moderating variables assessed |
| 25 | N=50 (all male) | Between subject: customary drinking | Cold pressor test (40 seconds; arm to the elbow) | Highest level of verbal report at intervals of 5 seconds | No main effects of alcohol reported | Customary drinking (Williams Problem Drinking Inventory): Pain reduction after alcohol consumption was correlated with three items (drinking to forget problems, drinking to be satisfied with oneself, drinking to increase self-confidence) |
| 28, experiment 1 | N=7 (all male) | Within subject: alcohol vs placebo | Pressure (bare area of the tibia) | Pain threshold | Pain threshold: pain-dampening effect of alcohol | No moderating variables assessed |
| 28, experiment 2 | N=7 (all male) | Within subject: alcohol vs morphine | Pressure (bare area of the tibia) | Pain threshold | Pain threshold: pain-dampening effect of alcohol and morphine; no significant difference between the treatments | No moderating variables assessed |
| 1 | N=51 (all male) | Between subject: high alcohol vs low alcohol vs placebo; customary drinking | 1. Pressure (2 minutes, middle phalanx of the index finger) | Pain threshold | No main effects of alcohol reported | Customary drinking: Customary bar drinkers experienced greater pain reduction with the high alcohol dose than customary family drinkers |
| 24 | N=79 (all male) | Between subject: alcoholism | Cold pressor test (40 seconds, arm to the elbow) | Highest level of verbal report at intervals of 5 seconds | Alcohol effect dependent on group | Alcoholism: Pain-dampening effect of alcohol only in alcoholics; nonalcoholics showed no changes in pain levels |
Notes:
as this investigation contains the results of two experiments, both experiments are listed separately.
Abbreviations: FHN, family history negative; FHP, family history positive; Ne, neuroticism; VAS, visual analog scale; NRS, numerical rating scale; IV, intravenous; DAS, Definitions of Alcohol Scale.